The results offer an insightful understanding toward of the GTPase activation cycle of the ROC domain as well as its role in regulating LRRK2 functionality, and such mechanistic insights provide guidance for targeting ROCs for tuning LRRK2 bioactivity for future PD treatment. This evidence concerns the gene LRRK2 and Parkinson disease.